SCHEMBL20546709

SCHEMBL20546709

CCOC(=O)N1CCc2noc(-c3ccc(C)cc3)c2CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.51
MAPK1 P28482 1/20 0.51
KMT2A Q03164 3/20 0.45
MEN1 O00255 2/20 0.45
POLB P06746 1/20 0.44
ADRB2 P07550 1/20 0.44
NPC1 O15118 2/20 0.43
RAB9A P51151 1/20 0.43
MAPT P10636 3/20 0.43
HTT P42858 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
PABPC1 P11940 1/20 0.42
ATM Q13315 1/20 0.42
ALDH1A1 P00352 5/20 0.42
TSHR P16473 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
ALOX15 P16050 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20547217 0.91 LMNA (0.47) LMNAMAPK1KMT2AMEN1NPC1
SCHEMBL20547362 0.91 SMN1; SMN2 (0.53) LMNAMAPK1KMT2AMEN1POLB
SCHEMBL20547218 0.91 KMT2A (0.51) LMNAKMT2AMEN1NPC1RAB9A
SCHEMBL20547359 0.86 DPP4 (0.48) LMNAMAPK1KMT2AMEN1NPC1
SCHEMBL20547285 0.82 KCNH2 (0.56) LMNAMAPK1KMT2AMEN1NPC1
SCHEMBL20547288 0.82 LMNA (0.50) LMNAKMT2AMEN1NPC1RAB9A
SCHEMBL20547293 0.81 NPC1 (0.54) LMNAKMT2APOLBNPC1RAB9A
SCHEMBL20547245 0.80 NPC1 (0.53) LMNAKMT2AMEN1POLBNPC1
SCHEMBL20547246 0.80 NPC1 (0.53) LMNAKMT2AMEN1POLBNPC1
SCHEMBL11830890 0.68 SMYD3 (0.53) LMNAMAPK1KMT2AMEN1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3560927-B1 AZEPINE DERIVATIVES ACTING AS 5-HT7 RECEPTOR MODULATORS KOREA INST SCI & TECH (KR) 2023-04-19 EP disclosed
EP-3560927-A1 AZEPINE DERIVATIVE ACTING AS 5-HT7 RECEPTOR MODULATOR Korea Institute of Science and Technology (KR) 2019-10-30 EP disclosed
US-10435408-B2 Azepine derivatives as 5-HT7 receptor modulators KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2019-10-08 US disclosed
US-20180312509-A1 AZEPINE DERIVATIVES AS 5-HT7 RECEPTOR MODULATORS KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2018-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180312509-A1 AZEPINE DERIVATIVES AS 5-HT7 RECEPTOR MODULATORS HTR7, HTR5A, HTR3A LMNA 2326/4885MAPK1 3294/4885KMT2A 2474/4885
US-10435408-B2 Azepine derivatives as 5-HT7 receptor modulators HTR7, HTR5A, HTR3A LMNA 2326/4885MAPK1 3294/4885KMT2A 2474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.